Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suncure Xt
- Development stage
- Unknown
- Lead developer
- Suncure Lifescience
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Suncure Xt** is an oral fixed-dose antianemic tablet marketed by Suncure Lifescience. The product is identified by its sponsor as containing ferrous ascorbate and folic acid, providing iron replacement and folate supplementation to treat or prevent iron deficiency anemia. ([suncurelife.com](https://www.suncurelife.com/Product-Detail/Suncure%20Xt%20Tablet))
- Brand names
- Suncure Xt
- Other names
- Suncure XTSUNCURE-XT
Beyond the preview
Go deeper on Suncure Xt.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suncure Xt.